Postoperative morbidity and mortality after neoadjuvant chemotherapy versus upfront surgery for locally advanced gastric cancer: a propensity score matching analysis

References

• Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29. doi:10.3322/caac.2120824399786
   PubMed Web of Science ®Google Scholar
• Russo A, Li P, Strong VE. Differences in the multimodal treatment of gastric cancer: east versus west. J Surg Oncol. 2017;115(5):603–614. doi:10.1002/jso.2459728181265
   PubMed Web of Science ®Google Scholar
• Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977–1010. doi:10.1016/S0140-6736(14)62038-925467588
   PubMed Web of Science ®Google Scholar
• Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11–20. doi:10.1056/NEJMoa05553116822992
   PubMed Web of Science ®Google Scholar
• Schuhmacher C, Gretschel S, Lordick F, et al. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: european organisation for research and treatment of cancer randomized trial 40954. J Clin Oncol. 2010;28(35):5210–8. doi:10.1200/JCO.2009.26.611421060024
   PubMed Web of Science ®Google Scholar
• Oki E, Emi Y, Kusumoto T, et al. Phase II study of docetaxel and S-1 (DS) as neoadjuvant chemotherapy for clinical stage III resectable gastric cancer. Ann Surg Oncol. 2014;21(7):2340–2346. doi:10.1245/s10434-014-3594-924604583
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Sasako M, Yamamoto S, et al. Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer. Br J Surg. 2009;96(9):1015–1022. doi:10.1002/bjs.v96:919644974
   PubMed Web of Science ®Google Scholar
• Kosaka T, Akiyama H, Makino H, et al. Preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer. Cancer Chemother Pharmacol. 2014;73(2):281–285. doi:10.1007/s00280-013-2350-324253176
   PubMed Web of Science ®Google Scholar
• Bonavina L, Soligo D, Quirici N, et al. Bone marrow-disseminated tumor cells in patients with carcinoma of the esophagus or cardia. Surgery. 2001;129(1):15–22. doi:10.1067/msy.2001.10950311150029
   PubMed Web of Science ®Google Scholar
• Fujitani K, Ajani JA, Crane CH, et al. Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junction. Ann Surg Oncol. 2007;14(7):2010–2017. doi:10.1245/s10434-006-9198-217342569
   PubMed Web of Science ®Google Scholar
• Valenti V, Hernandez-Lizoaín JL, Beorlegui MC, et al. Morbidity, mortality, and pathological response in patients with gastric cancer preoperatively treated with chemotherapy or chemoradiotherapy. J Surg Oncol. 2011;104(2):124–129. doi:10.1002/jso.v104.221509785
   PubMed Web of Science ®Google Scholar
• Ychou M, Boige V, Pignon J-P, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29(13):1715–1721. doi:10.1200/JCO.2010.33.059721444866
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009. doi:10.1016/j.jbi.2008.08.010
   PubMed Web of Science ®Google Scholar
• Washington K, Murray DR, Gow KW, et al. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17(12):3077–3079. doi:10.1245/s10434-010-1022-320882416
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-83558716
   PubMedGoogle Scholar
• Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213. doi:10.1097/01.sla.0000133083.54934.ae15273542
   PubMed Web of Science ®Google Scholar
• Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–196. doi:10.1097/SLA.0b013e3181b13ca219638912
   PubMed Web of Science ®Google Scholar
• Rubin DB. Using propensity scores to help design observational studies: application to the tobacco litigation. Health Serv Outcomes Res Methodol. 2001;2(3–4):169–188. doi:10.1023/A:1020363010465
   Google Scholar
• Rosenbaum PR. The central role of the propensity score in observational studies for causal effects In: Rubin DB, editor. Matched Sampling for Causal Effects. Cambridge University Press: Cambridge; 2006:170–184.
   Google Scholar
• Ali A, Husain A, Love TE, et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J. 2006;27(12):1431. doi:10.1093/eurheartj/ehi89016709595
   PubMed Web of Science ®Google Scholar
• Normand SLT, Landrum MB, Guadagnoli E, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol. 2001;54(4):387–398. doi:10.1016/S0895-4356(00)00321-811297888
   PubMed Web of Science ®Google Scholar
• Li ZY, Shan F, Zhang L-H, et al. Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer. World J Surg Oncol. 2011;9:110. doi:10.1186/1477-7819-9-11021942969
   PubMed Web of Science ®Google Scholar
• Nio Y, Kuroki M, Kuroki M, Badran A, Hachimine K, Kinugasa T. A randomized consent design trial of neoadjuvant chemotherapy with tegafur plus uracil (UFT) for gastric cancer–a single institute study. Anticancer Res. 2004;24(3b):1879–1887.15274369
   PubMed Web of Science ®Google Scholar
• Ahn HS, Jeong S-H, Son YG, et al. Effect of neoadjuvant chemotherapy on postoperative morbidity and mortality in patients with locally advanced gastric cancer. Br J Surg. 2014;101(12):1560–1565. doi:10.1002/bjs.2014.101.issue-1225200278
   PubMed Web of Science ®Google Scholar
• Fan CG, Li GL. [Effect of neoadjuvant chemotherapy on the postoperative pulmonary infection of patients with advanced gastric cancer]. Zhonghua Wei Chang Wai Ke Za Zhi. 2011;14(7):503–505.21792758
   PubMedGoogle Scholar
• Zhao Wen-He, Wang SF, Ding W, et al. Apoptosis induced by preoperative oral 5′-DFUR administration in gastric adenocarcinoma and its mechanism of action. World J Gastroenterol. 2006;12(9):1356–1361. doi:10.3748/wjg.v12.i9.135616552801
   PubMed Web of Science ®Google Scholar
• Tan BHL, Brammer K, Randhawa N, et al. Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer. Eur J Surg Oncol. 2015;41(3):333–338. doi:10.1016/j.ejso.2014.11.04025498359
   PubMed Web of Science ®Google Scholar
• Wagner, D., DeMarco MM, Amini N, Buttner S, Segev D, Gani F and Pawlik TM. Role of frailty and sarcopenia in predicting outcomes among patients undergoing gastrointestinal surgery. World J Gastrointest Surg. 2016;8(1):27–40. doi:10.4240/wjgs.v8.i1.2726843911
   PubMedGoogle Scholar